Back
EHRA Premium Access

The mitral valve in patients with AF and HF - Do we need specific therapy?

Session: New insights on atrial fibrillation in patients with HFrEF and HFpEF: treatment strategies to optimise outcome
Topic: Heart Failure and Left Ventricular Dysfunction
Speaker: Professor R. Rosenhek (Vienna, AT)
Event: EHRA 2018

Congress Presentation

About the speaker

Professor Raphael Rosenhek

Medical University of Vienna, Vienna (Austria)
27 presentations
2 followers

3 more presentations in this session

The impact of atrial fibrillation in HFREF and HFPEF

Speaker: Professor A. Stewart Coats (Sydney, AU)

Access
Slides
Video
Thumbnail

Is there a role for anti-arrhythmic drugs or catheter ablation?

Speaker: Professor F. Ruschitzka (Zurich, CH)

Access
Slides
Video
Thumbnail

Permanent atrial fibrillation in HFREF and HFPEF: when and how to control rate?

Speaker: Professor D. Kotecha (Birmingham, GB)

Access
Slides
Video
Thumbnail

Access the full session

New insights on atrial fibrillation in patients with HFrEF and HFpEF: treatment strategies to optimise outcome

Speakers: Professor R. Rosenhek, Professor A. Stewart Coats, Professor F. Ruschitzka, Professor D. Kotecha
Access
Thumbnail

About the event

Image

EHRA 2018

18 March - 20 March 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb